|
Volumn 33, Issue 5, 2008, Pages 1162-1170
|
Bupropion for the treatment of methamphetamine dependence
a b a a c a a a a b b d e f g g h i
f
IQVIA
(United States)
|
Author keywords
Addiction; Bupropion; Drug abuse; Methamphetamine; Risk factors; Severity of illness index
|
Indexed keywords
AMFEBUTAMONE;
METHAMPHETAMINE;
PLACEBO;
UNCLASSIFIED DRUG;
ZYBAN SR;
ABSTINENCE;
ARTICLE;
ATTENTION DEFICIT DISORDER;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG DEPENDENCE;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
FEMALE;
GROUP THERAPY;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
METHAMPHETAMINE DEPENDENCE;
MULTICENTER STUDY;
MULTIPLE DRUG ABUSE;
OUTPATIENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SELF REPORT;
STATISTICAL MODEL;
STATISTICAL SIGNIFICANCE;
SUSTAINED RELEASE FORMULATION;
TREATMENT OUTCOME;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
URINALYSIS;
WITHDRAWAL SYNDROME;
ADULT;
AMPHETAMINE-RELATED DISORDERS;
BUPROPION;
DOPAMINE UPTAKE INHIBITORS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
METHAMPHETAMINE;
MIDDLE AGED;
MISSISSIPPI;
PSYCHOTHERAPY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 40549145546
PISSN: 0893133X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.npp.1301481 Document Type: Article |
Times cited : (178)
|
References (45)
|